These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2481338)

  • 21. Molecular mapping of a histocompatibility-restricted immunodominant T cell epitope with synthetic and natural peptides: implications for T cell antigenic structure.
    Berkower I; Buckenmeyer GK; Berzofsky JA
    J Immunol; 1986 Apr; 136(7):2498-503. PubMed ID: 2419437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic peptide-targeted selection of phage display mimotopes highlights immunogenic features of α-helical vs non-helical epitopes of Taenia solium paramyosin: implications for parasite- and host-protective roles of the protein.
    Gazarian KG; Solis CF; Gazarian TG; Rowley M; Laclette JP
    Peptides; 2012 Mar; 34(1):232-41. PubMed ID: 22015270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.
    Udhayakumar V; Anyona D; Kariuki S; Shi YP; Bloland PB; Branch OH; Weiss W; Nahlen BL; Kaslow DC; Lal AA
    J Immunol; 1995 Jun; 154(11):6022-30. PubMed ID: 7538540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.
    Su H; Morrison RP; Watkins NG; Caldwell HD
    J Exp Med; 1990 Jul; 172(1):203-12. PubMed ID: 1694217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of amino acid substitutions and beta-N- vs. alpha-O-glycosylation on the T-cell stimulatory activity and conformation of an epitope on the rabies virus glycoprotein.
    Otvos L; Krivulka GR; Urge L; Szendrei GI; Nagy L; Xiang ZQ; Ertl HC
    Biochim Biophys Acta; 1995 May; 1267(1):55-64. PubMed ID: 7540044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polarity of immunogens: implications for vaccine design.
    Golvano J; Lasarte JJ; Sarobe P; Gullón A; Prieto J; Borrás-Cuesta F
    Eur J Immunol; 1990 Oct; 20(10):2363-6. PubMed ID: 1700756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of immunodominant epitopes by contiguous sequences in complex synthetic peptides.
    Wang Y; Smith JA; Kamradt T; Gefter ML; Perkins DL
    Cell Immunol; 1992 Sep; 143(2):284-97. PubMed ID: 1380894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein.
    Su H; Caldwell HD
    J Exp Med; 1992 Jan; 175(1):227-35. PubMed ID: 1370528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
    Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes.
    Bright RK; Shearer MH; Kennedy RC
    Clin Exp Immunol; 1994 Jun; 96(3):491-9. PubMed ID: 7516272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breakage in alpha-helix: a recognition site for anti-rabies virus ribonucleoprotein antibody.
    Otvos L; Dietzschold B; Hollosi M; Gore M; Kajtar J; Niu H; Koprowski H
    Pept Res; 1989; 2(2):167-70. PubMed ID: 2520753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of synthetic T-cell epitopes as immunogens to induce antibodies to hepatitis B components.
    Milich DR; Thornton GB
    Methods Enzymol; 1989; 178():634-59. PubMed ID: 2481218
    [No Abstract]   [Full Text] [Related]  

  • 34. Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides.
    Burt DS; Mills KH; Skehel JJ; Thomas DB
    J Exp Med; 1989 Aug; 170(2):383-97. PubMed ID: 2474053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
    Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
    J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
    J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
    Fangmann J; Dalchau R; Fabre JW
    J Exp Med; 1992 Jun; 175(6):1521-9. PubMed ID: 1588278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices.
    Zhou NE; Mant CT; Hodges RS
    Pept Res; 1990; 3(1):8-20. PubMed ID: 2134049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of the physical properties of peptides that influence the pigeon cytochrome c specific T lymphocyte response.
    Collawn JF; Bhayani H; Paterson Y
    Mol Immunol; 1989 Nov; 26(11):1069-79. PubMed ID: 2481824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction.
    Milich DR; Jones JE; McLachlan A; Houghten R; Thornton GB; Hughes JL
    J Immunol; 1989 Nov; 143(10):3148-56. PubMed ID: 2478619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.